Silicon Valley computer history, heritage neighborhoods, museums, parks, restaurants — and a mysterious 160-room mansion ...
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Also check out A Charity Raffle for Bourbon Lovers on the Concord Patch calendar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback